Matches in Wikidata for { <http://www.wikidata.org/entity/Q99956151> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q99956151 description "clinical trial" @default.
- Q99956151 description "ensayo clínico" @default.
- Q99956151 description "ensayu clínicu" @default.
- Q99956151 description "klinisch onderzoek" @default.
- Q99956151 description "клінічне випробування" @default.
- Q99956151 description "临床试验" @default.
- Q99956151 name "Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Ankylosing Spondylitis Who Are Naive to Biologic Disease-Modifying Antirheumatic Drug Therapy" @default.
- Q99956151 name "Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Ankylosing Spondylitis Who Are Naive to Biologic Disease-Modifying Antirheumatic Drug Therapy" @default.
- Q99956151 type Item @default.
- Q99956151 label "Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Ankylosing Spondylitis Who Are Naive to Biologic Disease-Modifying Antirheumatic Drug Therapy" @default.
- Q99956151 label "Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Ankylosing Spondylitis Who Are Naive to Biologic Disease-Modifying Antirheumatic Drug Therapy" @default.
- Q99956151 prefLabel "Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Ankylosing Spondylitis Who Are Naive to Biologic Disease-Modifying Antirheumatic Drug Therapy" @default.
- Q99956151 prefLabel "Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Ankylosing Spondylitis Who Are Naive to Biologic Disease-Modifying Antirheumatic Drug Therapy" @default.
- Q99956151 P1050 Q99956151-A5C7E183-DBEE-4FBB-A5CD-C959BFBA5385 @default.
- Q99956151 P1132 Q99956151-D0C54632-A0DE-4442-98EF-5C6AF6ECB84F @default.
- Q99956151 P1476 Q99956151-4DE07D38-C303-47B1-B393-0F9AED2D5675 @default.
- Q99956151 P1813 Q99956151-96162FBD-8002-4A5E-A54D-83FFFEC60C87 @default.
- Q99956151 P2899 Q99956151-9B091FE4-31D3-4D9A-8B6A-103E9176A7CA @default.
- Q99956151 P3098 Q99956151-17682410-2482-4374-89BD-A37659BB1C68 @default.
- Q99956151 P31 Q99956151-7AFCE897-89F6-4D36-AD81-1F5BEB8B587C @default.
- Q99956151 P580 Q99956151-D8018E16-8531-4ECF-893B-4983FFAB8A47 @default.
- Q99956151 P582 Q99956151-33865CE9-F7CC-45E8-9960-CBA071FD7CA8 @default.
- Q99956151 P6099 Q99956151-98614508-4878-4730-8398-6501030A01D7 @default.
- Q99956151 P8005 Q99956151-5FB582C4-D826-421C-87F2-6532E44B8277 @default.
- Q99956151 P8363 Q99956151-2115E165-F202-4F2E-9BC6-1EC399B60F91 @default.
- Q99956151 P1050 Q2165411 @default.
- Q99956151 P1132 "+408" @default.
- Q99956151 P1476 "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Filgotinib in Subjects With Active Ankylosing Spondylitis Who Are Naive to Biologic Disease-Modifying Antirheumatic Drug Therapy" @default.
- Q99956151 P1813 "SEALION2-NAÏVE" @default.
- Q99956151 P2899 "+18" @default.
- Q99956151 P3098 "NCT04483700" @default.
- Q99956151 P31 Q30612 @default.
- Q99956151 P580 "2020-10-01T00:00:00Z" @default.
- Q99956151 P582 "2022-08-01T00:00:00Z" @default.
- Q99956151 P6099 Q42824827 @default.
- Q99956151 P8005 Q76649614 @default.
- Q99956151 P8363 Q78089383 @default.